Published in Endoscopy on July 01, 2007
Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst (2011) 4.31
The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65
Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg (2015) 1.45
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology (2015) 1.10
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. J Cell Mol Med (2008) 0.95
Natural history of Barrett's esophagus. World J Gastroenterol (2012) 0.93
Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett's esophagus surveillance program. Dig Dis Sci (2012) 0.88
Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology (2015) 0.81
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am (2015) 0.79
Barrett's Esophagus: Emerging Knowledge and Management Strategies. Patholog Res Int (2012) 0.78
Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. J Neurogastroenterol Motil (2013) 0.77
Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol (2012) 0.76
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. Gastrointest Cancer Res (2012) 0.76
Prospector: A web-based tool for rapid acquisition of gold standard data for pathology research and image analysis. J Pathol Inform (2015) 0.75
Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus. United European Gastroenterol J (2016) 0.75
Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists. World J Gastroenterol (2016) 0.75
Low grade dysplasia in Barrett's esophagus: Should we worry? World J Gastrointest Pathophysiol (2014) 0.75
Current Controversies in Radiofrequency Ablation Therapy for Barrett's Esophagus. Curr Treat Options Gastroenterol (2016) 0.75
Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus. World J Gastroenterol (2015) 0.75
Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol (2017) 0.75
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology (2005) 2.02
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia. Aliment Pharmacol Ther (2005) 1.84
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72
Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56
Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50
The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology (1999) 1.47
The appendix as a 'skip lesion' in ulcerative colitis. Histopathology (1990) 1.46
Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer (1997) 1.45
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology (1993) 1.45
Anaplastic gastric adenocarcinoma with extensive neutrophilic infiltration. Histopathology (1998) 1.44
Vasculitis in ileocaecal tuberculosis: similarities to Crohn's disease. Histopathology (1992) 1.43
Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.42
Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur J Gastroenterol Hepatol (1995) 1.42
Progressive vaccinia complicating lymphosarcoma. J Pathol (1970) 1.41
Fatal accidental ingestion of Clinitest in adult. J R Soc Med (1984) 1.39
DNA aneuploidy in ulcerative colitis. Gut (1986) 1.38
ACP Broadsheet 133: November 1992. Gross examination of the stomach. J Clin Pathol (1992) 1.38
Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg (1993) 1.38
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer (2010) 1.37
Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut (1980) 1.37
Adhesion molecules in inflammatory bowel disease. Gut (1995) 1.36
Reflux gastritis in the intact stomach. J Clin Pathol (1990) 1.35
Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer (1985) 1.34
DNA aneuploidy in colorectal adenomas. Br J Cancer (1986) 1.32
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut (1993) 1.32
Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut (2003) 1.32
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J Clin Pathol (1985) 1.29
Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease. Gut (1983) 1.28
Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol (1999) 1.28
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Aliment Pharmacol Ther (2002) 1.27
Quantitation of intraepithelial lymphocytes in human duodenum: what is normal? J Clin Pathol (2002) 1.26
Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology (1994) 1.26
Small bowel haemangioma with local lymph node involvement presenting as intussusception. J Clin Pathol (2000) 1.24
Actinomycosis complicating chronic diverticulitis of the sigmoid colon: a missed association? Postgrad Med J (1992) 1.20
The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology (1986) 1.18
Bile reflux gastritis and intestinal metaplasia at the cardia. Gut (2002) 1.17
Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol (1998) 1.17
The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis. Infect Immun (1997) 1.16
Post-irradiation somatic mutation and clonal stabilisation time in the human colon. Gut (1996) 1.13
Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection. J Pathol (2004) 1.13
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter (2000) 1.12
Staphylococcal enterocolitis and inflammatory bowel disease. J Clin Pathol (1980) 1.11
The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther (1990) 1.10
Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol (1994) 1.09